Spatial memory impairments in a prediabetic rat model

Neuroscience

Volumn 250, Issue , 2013, Pages 565-577

  Soares, E ^a   Prediger, R D ^b   Nunes, S ^a   Castro, A A ^b   Viana, S D ^a   Lemos, C ^c   De Souza, C M ^c   Agostinho, P ^c   Cunha, R A ^c   Carvalho, E ^c,d   Fontes Ribeiro, C A ^a   Reis, F ^a   Pereira, F C ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^c UNIVERSITY OF COIMBRA   (Portugal)

^d APDP   (Portugal)

Author keywords

Diabetic encephalopathy; High sucrose diet; Hippocampus; Memory; Prediabetes

Indexed keywords

4 HYDROXYNONENAL; ADVANCED GLYCATION END PRODUCT RECEPTOR; AMPA RECEPTOR; CORTICOSTERONE; GLUCOCORTICOID RECEPTOR; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROTEIN GLUA1; PROTEIN GLUN1; SYNAPTOPHYSIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; HIPPOCAMPUS; HYPERINSULINEMIA; HYPERTRIGLYCERIDEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; LONG TERM MEMORY; MALE; MAZE TEST; MEMORY DISORDER; MENTAL PERFORMANCE; NONHUMAN; PRIORITY JOURNAL; RAT; SHORT TERM MEMORY; SPATIAL LEARNING; SPATIAL MEMORY; SUGAR INTAKE;

ANALYSIS OF VARIANCE; ANOVA; AREA UNDER THE CURVE; AUC; BBB; BLOOD-BRAIN BARRIER; CONT; CONTROL; DIABETIC ENCEPHALOPATHY; EGTA; ELISA; ENZYME-LINKED IMMUNOSORBENT ASSAY; ETHYLENE GLYCOL TETRAACETIC ACID; GAPDH; GFAP; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUCOCORTICOID RECEPTOR; GLUCOSE TOLERANCE TEST; GLUTAMINE SYNTHETASE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; GR; GS; GTT; HFD; HIGH-FAT DIET; HIGH-SUCROSE; HIGH-SUCROSE DIET; HIPPOCAMPUS; HNE; HOMA; HOMEOSTASIS MODEL ASSESSMENT INDEX; HPA; HSU; HYDROXYNONENAL; HYPOTHALAMIC-PITUITARY-ADRENAL; IGT; IMPAIRED GLUCOSE TOLERANCE; INSULIN TOLERANCE TEST; ITT; MEMORY; N-METHYL-D-ASPARTATE RECEPTOR; NMDAR; PBS-T; PHOSPHATE-BUFFERED SALINE WITH 0.1% TWEEN-20; POSTSYNAPTIC DENSITY PROTEIN 95; PREDIABETES; PSD-95; RAGE; RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS; STREPTOZOTOCIN; STZ; T2DM; TGS; TNF-Α; TRIGLYCERIDES; TUMOR NECROSIS FACTOR Α; TYPE 2 DIABETES MELLITUS; ZDF; ZUCKER DIABETIC FATTY;

ANALYSIS OF VARIANCE; ANIMALS; BLOOD GLUCOSE; CYTOKINES; DIET; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HIPPOCAMPUS; LIPIDS; MALE; MAZE LEARNING; MEMORY DISORDERS; NERVE TISSUE PROTEINS; OXIDATIVE STRESS; PREDIABETIC STATE; PSYCHOMOTOR PERFORMANCE; RATS; RATS, WISTAR; RECEPTOR, INSULIN; RECEPTORS, AMPA; RECEPTORS, GLUCOCORTICOID; RECEPTORS, GLUTAMATE; RECEPTORS, N-METHYL-D-ASPARTATE; SPACE PERCEPTION; SUCROSE;

EID: 84882959210     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2013.07.055     Document Type: Article

References (86)

1. Arancio O., Zhang H.P., Chen X., Lin C., Trinchese F., Puzzo D., Liu S., Hegde A., Yan S.F., Stern A., Luddy J.S., Lue L.F., Walker D.G., Roher A., Buttini M., Mucke L., Li W., Schmidt A.M., Kindy M., Hyslop P.A., Stern D.M., Du Yan S.S. RAGE potentiates Abeta-induced perturbation of neuronal function in transgenic mice. EMBO J 2004, 23:4096-4105.
2. Baker L.D., Cross D., Minoshima S., Belongia D., Stennis G., Watson Craft.S. Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes. Arch Neurol 2011, 68:51-57.
3. Banks W.A. The source of cerebral insulin. Eur J Pharmacol 2004, 490:5-12.
4. Banks W.A., Coon A.B., Robinson S.M., Moinuddin A., Shultz J.M., Nakaoke R., Morley J.E. Triglycerides induce leptin resistance at the blood-brain barrier. Diabetes 2004, 53:1253-1260.
5. Banks W.A., Burney B.O., Robinson S.M. Effects of triglycerides, obesity, and starvation on ghrelin transport across the blood-brain barrier. Peptides 2008, 29:2061-2065.
6. Beauquis J., Homo-Delarche F., Giroix M.-H., Ehses J., Coulaud J., Roig P., Portha B., De Nicola A.F., Saravia F. Hippocampal neurovascular and hypothalamic-pituitary-adrenal axis alterations in spontaneously type 2 diabetic GK rats. Exp Neurol 2010, 222:125-134.
7. Bekker A., Shah R., Quartermain D., Li Y.S., Blanck T. Isoflurane preserves spatial working memory in adult mice after moderate hypoxia. Anesth Analg 2006, 102:1134-1138.
8. Bélanger A., Lavoie N., Trudeau F., Massicotte G., Gagnon S. Preserved LTP and water maze learning in hyperglycaemic-hyperinsulinemic ZDF rats. Physiol Behav 2004, 83:483-494.
9. Biessels G.J., van der Heide L., Kamal A., Bleys R., Gispen W. Ageing and diabetes: implications for brain function. Eur J Pharmacol 2002, 44:1-14.
10. Bruehl H., Wolf O.T., Sweat V., Tirsi A., Richardson S., Convit A. Modifiers of cognitive function and brain structure in middle-aged and elderly individuals with type 2 diabetes mellitus. Brain Res 2009, 1280:186-194.
11. Cao D., Lu H., Lewis T.L., Li L. Intake of sucrose-sweetened water induces insulin resistance and exacerbates memory deficits and amyloidosis in a transgenic mouse model of Alzheimer disease. J Biol Chem 2007, 282:36275-36282.
12. Carvalho C., Cardoso S., Correia S.C., Santos R.X., Santos M.S., Baldeiras I., Oliveira C.R., Moreira P.I. Metabolic alterations induced by sucrose intake and Alzheimer's disease promote similar brain mitochondrial abnormalities. Diabetes 2012, 61:1234-1242.
13. Castro A.A., Wiemes B.P., Matheus F.C., Lapa F.R., Viola G.G., Santos A.R., Tasca C.I., Prediger R.D. Atorvastatin improves cognitive, emotional and motor impairments induced by intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration in rats, an experimental model of Parkinson's disease. Brain Res 2013, 1513:103-116.
14. Cha S.H., Lane M.D. Central lactate metabolism suppresses food intake via the hypothalamic AMP kinase/malonyl-CoA signaling pathway. Biochem Biophys Res Commun 2009, 386:212-216.
15. Chepulis L.M., Starkey N.J., Waas J.R., Molan P.C. The effects of long-term honey, sucrose or sugar-free diets on memory and anxiety in rats. Physiol Behav 2009, 97:359-368.
16. 2A receptor antagonists prevent memory impairment and synaptotoxicity in adult rats triggered by a convulsive episode in early life. J Neurochem 2010, 112:453-462.
17. Conde S.V., Nunes da Silva T., Gonzalez C., Mota Carmo M., Monteiro E.C., Guarino M.P. Chronic caffeine intake decreases circulating catecholamines and prevents diet-induced insulin resistance and hypertension in rats. Br J Nutr 2011, 1071:86-95.
18. Convit A. Links between cognitive impairment in insulin resistance: an explanatory model. Neurobiol Aging 2005, 26:31-35.
19. Costello D.A., Claret M., Al-Qassab H., Plattner F., Irvine E.E., Choudhury A.I., Giese P., Withers D.J., Pedarzani P. Brain deletion of insulin receptor substrate 2 disrupts hippocampal synaptic plasticity and metaplasticity. PLoS One 2012, 7:31124.
20. Craft S., Watson G.S. Insulin and neurodegenerative disease: shared and specific mechanisms. Lancet Neurol 2004, 3:169-178.
21. Dellu F., Fauchey V., LeMoal M., Simon H. Extension of a new two-trial memory task in the rat: influence of environmental context on recognition processes. Neurobiol Learn Mem 1997, 67:112-120.
22. Di Luca M., Ruts L., Gardoni F., Cattabeni F., Biessels G.J., Gispen W.H. NMDA receptor subunits are modified transcriptionally and post-translationally in the brain of streptozotocin-diabetic rats. Diabetologia 1999, 42:693-701.
23. Dorey R., Piérard C., Chauveau F., David V., Béracochéa D. Stress-induced memory retrieval impairments: different time-course involvement of corticosterone and glucocorticoid receptors in dorsal and ventral hippocampus. Neuropsychopharmacology 2012, 37:2870-2880.
24. 2A receptor density in the hippocampus of streptozotocin-induced diabetic rats. Neurochem Int 2006, 48:144-150.
25. Duarte J.M., Agostinho P.M., Carvalho R.A., Cunha R.A. Caffeine consumption prevents diabetes-induced memory impairment and synaptotoxicity in the hippocampus of NONcZNO10/LTJ mice. PLoS One 2012, 7:21899.
26. Escribano L., Simón A.-M., Pérez-Mediavilla A., Salazar-Colocho P., Del Río J., Frechilla D. Rosiglitazone reverses memory decline and hippocampal glucocorticoid receptor down-regulation in an Alzheimer's disease mouse model. Biochem Biophys Res Commun 2009, 379:406-410.
27. Fang F., Lue L.F., Yan S., Xu H., Luddy J.S., Chen D., Walker D.G., Stern D.M., Schmidt A.M., Chen J.X., Yan S.S. RAGE-dependent signaling in microglia contributes to neuroinflammation, Abeta accumulation, and impaired learning/memory in a mouse model of Alzheimer's disease. FASEB J 2010, 24:1043-1055.
28. Farr S.A., Yamada K.A., Butterfield D.A., Abdul H.M., Xu L., Miller N.E., Banks W.A., Morley J.E. Obesity and hypertriglyceridemia produce cognitive impairment. Endocrinology 2008, 149:2628-2636.
29. Gao L., Matthews F.E., Sargeant L.A., Brayne C. An investigation of the population impact of variation in HbA1c levels in older people in England and Wales: from a population based multi-centre longitudinal study. BMC Public Health 2008, 8:54.
30. Gold S., Dziobek I., Sweat V., Tirsi A., Rogers K., Bruehl H., Tsui W., Richardson S., Javier E., Convit A. Hippocampal damage and memory impairments as possible early brain complications of Type 2 diabetes. Diabetologia 2007, 50:711-719.
31. Hernández-Fonseca J., Rincón J., Pedreañez A., Viera N., Arcaya J., Carrizo E., Mosquera J. Structural and ultrastructural analysis of cerebral cortex, cerebellum, and hypothalamus from diabetic rats. Exp Diabetes Res 2009, 329632:1-12.
32. Hwang I.K., Yi S.S., Yoo K.-Y., Park O.K., Yan B., Song W., Won M.-H., Yoon Y.S., Seong J.K. Effect of treadmill exercise on blood glucose, serum corticosterone levels and glucocorticoid receptor immunoreactivity in the hippocampus in chronic diabetic rats. Neurochem Res 2011, 36:281-287.
33. Kamal A., Biessels G.J., Duis S.E., Gispen W.H. Learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: interaction of diabetes and ageing. Diabetologia 2000, 43:500-506.
34. Kanazawa M., Xue C.Y., Kageyama H., Suzuki E., Ito R., Namba Y., Osaka T., Kimura S., Inoue S. Effects of a high-sucrose diet on body weight, plasma triglycerides, and stress tolerance. Nutr Rev 2003, 61:S27-S33.
35. Kosari S., Badoer E., Nguyen J.C.D., Killcross A.S., Jenkins T.A. Effect of western and high fat diets on memory and cholinergic measures in the rat. Behav Brain Res 2012, 235:98-103.
36. Kuwabara T., Kagalwala M.N., Onuma Y., Ito Y., Warashina M., Terashima K., Nakashima K., Gage F.H., Asashima M. Insulin biosynthesis in neuronal progenitors derived from adult hippocampus and the olfactory bulb. EMBO Mol Med 2011, 3:742-754.
37. Leboucher A., Laurent C., Fernandez-Gomez F.J., Burnouf S., Troquier L., Eddarkaoui S., Demeyer D., Caillierez R., Zommer N., Vallez E., Bantubungi K., Breton C., Pigny P., Buée-Scherrer V., Staels B., Hamdane M., Tailleux A., Buée L., Blum D. Detrimental effects of diet-induced obesity on τ pathology are independent of insulin resistance in τ transgenic mice. Diabetes 2013, 62:1681-1688.
38. Lee H.K. AMPA receptor phosphorylation in synaptic plasticity: insights from knockin mice. The dynamic synapse: molecular methods in ionotropic receptor biology 2006, CRC Press, Boca Raton (FL), [Frontiers in Neuroscience]. J.T. Kittler, S.J. Moss (Eds.).
39. Li N., Young M.M., Bailey C.J., Smith M.E. NMDA and AMPA glutamate receptor subtypes in the thoracic spinal cord in lean and obese-diabetic ob/ob mice. Brain Res 1999, 849:34-44.
40. Li B., Chen N., Luo T., Otsu Y., Murphy T.H., Raymond L.A. Differential regulation of synaptic and extra-synaptic NMDA receptors. Nat Neurosci 2002, 5:833-834.
41. Liu Y.W., Zhu X., Li W., Lu Q., Wang J.Y., Wei Y.Q., Yin X.X. Ginsenoside Re attenuates diabetes associated cognitive deficits in rats. Pharmacol Biochem Behav 2012, 101:93-98.
42. Maczurek A., Shanmugam K., Münch G. Inflammation and the redox-sensitive AGE-RAGE pathway as a therapeutic target in Alzheimer's disease. Ann N Y Acad Sci 2008, 1126:147-151.
43. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 1985, 28:412-419.
44. McNay E.C., Recknagel A.K. Brain insulin signaling: a key component of cognitive processes and a potential basis for cognitive impairment in type 2 diabetes. Neurobiol Learn Mem 2011, 96:432-442.
45. McNay E.C., Ong C.T., McCrimmon R.J., Cresswell J., Bogan J.S., Sherwin R.S. Hippocampal memory processes are modulated by insulin and high-fat-induced insulin resistance. Neurobiol Learn Mem 2010, 93:546-553.
46. Mielke J.G., Taghibiglou C., Liu L., Zhang Y., Jia Z., Adeli K., Wang Y.T. A biochemical and functional characterization of diet-induced brain insulin resistance. J Neurochem 2005, 93:1568-1578.
47. Mijnhout G.S., Scheltens P., Diamant M., Biessels G.J., Wessels A.M., Simsek S., Snoek F.J., Heine R.J. Diabetic encephalopathy: a concept in need of a definition. Diabetologia 2006, 49:1447-1448.
48. Molteni R., Barnard R.J., Ying Z., Roberts C.K., Gómez-Pinilla F. A high-fat, refined sugar diet reduces hippocampal brain-derived neurotrophic factor, neuronal plasticity, and learning. Neuroscience 2002, 112:803-814.
49. Morris R.G., Garrud P., Rawlins J.N., O'Keefe J. Place navigation impaired in rats with hippocampal lesions. Nature 1982, 297:681-683.
50. Nisticò R., Cavallucci V., Piccinin S., Macrì S., Pignatelli M., Mehdawy B., Blandini F., Laviola G., Lauro D., Mercuri N.B., D'Amelio M. Receptor β-subunit haploinsufficiency impairs hippocampal late-phase LTP and recognition memory. Neuromol Med 2012, 14:262-269.
51. Pekny M., Nilsson M. Astrocyte activation and reactive gliosis. Glia 2005, 50:427-434.
52. Pistell P.J., Morrison C.D., Gupta S., Knight A.G., Keller J.N., Ingram D.K., Bruce-Keller A.J. Cognitive impairment following high fat diet consumption is associated with brain inflammation. J Neuroimmunol 2010, 219:25-32.
53. Prediger R.D., Batista L.C., Medeiros R., Pandolfo P., Florio J.C., Takahashi R.N. The risk is in the air: Intranasal administration of MPTP to rats reproducing clinical features of Parkinson's disease. Exp Neurol 2006, 202:391-403.
54. Ramasamy R., Vannucci S.J., Yan S.S., Herold K., Yan S.F., Schmidt A.M. Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation. Glycobiology 2005, 15:16-28.
55. Ravona-Springer R., Moshier E., Schmeidler J., Godbold J., Akrivos J., Rapp M., Grossman H.T., Wysocki M., Silverman J.M., Haroutunian V., Beeri M.S. Changes in glycemic control are associated with changes in cognition in non-diabetic elderly. J Alzheimers Dis 2012, 30:299-309.
56. Ribeiro R.T., Lautt W.W., Legare D.J., Macedo M.P. Insulin resistance induced by sucrose feeding in rats is due to an impairment of the hepatic parasympathetic nerves. Diabetologia 2005, 48:976-983.
57. Ristow M. Neurodegenerative disorders associated with diabetes mellitus. J Mol Med 2004, 82:510-529.
58. Roriz-Filho J., Sá-Roriz T.M., Rosset I., Camozzato A.L., Santos A.C., Chaves M.L., Moriguti J.C., Roriz-Cruz M. (Pre)diabetes, brain aging, and cognition. Biochim Biophys Acta 2009, 1792:432-443.
59. Ross A.P., Bartness T.J., Mielke J.G., Parent M.B. A high fructose diet impairs spatial memory in male rats. Neurobiol Learn Mem 2009, 92:410-416.
60. Santos S.D., Carvalho A.L., Caldeira M.V., Duarte C.B. Regulation of AMPA receptors and synaptic plasticity. Neuroscience 2009, 158:105-125.
61. Santuré M., Pitre M., Marette A., Deshaies Y., Lemieux C., Larivière R., Nadeau A., Bachelard H. Induction of insulin resistance by high-sucrose feeding does not raise mean arterial blood pressure but impairs hemodynamic responses to insulin in rats. Br J Pharmacol 2002, 137:185-196.
62. Shin JH, Seong JK, Yi SS (2013) Sequential alterations of glucocorticoid receptors in the hippocampus of STZ-induced type 1 diabetic rats. J Vet Sci (in press).
63. Sima A.A. Encephalopathies: the emerging diabetic complications. Acta Diabetol 2010, 47:279-293.
64. Simões P.F., Silva A.P., Pereira F.C., Marques E., Grade S., Milhazes N., Borges F., Ribeiro C.F., Macedo T.R. Methamphetamine induces alterations on hippocampal NMDA and AMPA receptor subunit levels and impairs spatial working memory. Neuroscience 2007, 150:433-441.
65. Smith P., Krohn R., Hermanson G., Mallia A., Gartner F., Provenzano M., Fujimoto E., Goeke N., Olson B., Klenk D. Measurement of protein using bicinchoninic acid. Anal Biochem 1985, 150:76-85.
66. Sousa N., Almeida O.F. Corticosteroids: sculptors of the hippocampal formation. Rev Neurosci 2002, 13:59-84.
67. Steyn N.P., Mann J., Bennett P.H., Temple N., Zimmet P., Tuomilehto J., Lindström J., Louheranta A. Diet, nutrition and the prevention of type 2 diabetes. Public Health Nutr 2004, 7:147-165.
68. Strachan M., Deary I., Ewing F., Frier B. Is type II diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies. Diabetes Care 1997, 20:438-445.
69. Stranahan A.M., Arumugam T.V., Cutler R.G., Lee K., Egan J.M., Mattson M.P. Diabetes impairs hippocampal function through glucocorticoid-mediated effects on new and mature neurons. Nat Neurosci 2008, 11:309-317.
70. Stranahan A.M., Norman E.D., Lee K., Cutler R.G., Telljohann R.S., Egan J.M., Mattson M.P. Diet-induced insulin resistance impairs hippocampal synaptic plasticity and cognition in middle-aged rats. Hippocampus 2008, 18:1085-1088.
71. Sumiyoshi M., Sakanaka M., Kimura Y. Chronic intake of high-fat and high-sucrose diets differentially affects glucose intolerance in mice. J Nutr 2006, 136:582-587.
72. Tabák A.G., Herder C., Rathmann W., Brunner E.J., Kivimäki M. Prediabetes: a high-risk state for diabetes development. Lancet 2012, 379:2279-2290.
73. Talbot K., Wang H.Y., Kazi H., Han L.Y., Bakshi K.P., Stucky A., Fuino R.L., Kawaguchi K.R., Samoyedny A.J., Wilson R.S., Arvanitakis Z., Schneider J.A., Wolf B.A., Bennett D.A., Trojanowski J.Q., Arnold S.E. Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest 2012, 122:1316-1338.
74. Thresher J.S., Podolin D.A., Wei Y., Mazzeo R.S., Pagliassotti M.J. Comparison of the effects of sucrose and fructose on insulin action and glucose tolerance. Am J Physiol 2000, 279:1334-1340.
75. Trudeau F., Gagnon S., Massicotte G. Hippocampal synaptic plasticity and glutamate receptor regulation: influences of diabetes mellitus. Eur J Pharmacol 2004, 490:177-186.
76. Turrigiano G.G., Leslie K.R., Desai N.S., Rutherford L.C., Nelson S.B. Activity-dependent scaling of quantal amplitude in neocortical neurons. Nature 1998, 391:892-896.
77. Urayama A., Banks W.A. Starvation and triglycerides reverse the obesity-induced impairment of insulin transport at the blood-brain barrier. Endocrinology 2008, 149:3592-3597.
78. van der Heide L.P., Remarkers G.M.J., Marten P.S. Insulin signaling in the central nervous system: learning to survive. Prog Neurobiol 2006, 79:205-221.
79. Wallum B.J., Taborsky G.J., Porte D., Figlewicz D.P., Jacobson L., Beard J.C., Ward W.K., Dorsa D. Cerebrospinal fluid insulin levels increase during intravenous insulin infusions in man. J Clin Endocrinol Metab 1987, 64:1190-1194.
80. Wilson J.S., Mruthinti S., Buccafusco J.J., Schade R.F., Mitchell M.B., Harrell D.U., Gulati N.K., Miller Stephen L. Anti-RAGE and A immunoglobulin levels are related to dementia level and cognitive performance. J Gerontol 2009, 64:264-271.
81. Winocur G., Greenwood C.E. The effects of high fat diets and environmental influences on cognitive performance in rats. Behav Brain Res 1999, 101:153-161.
82. Winocur G., Greenwoond C., Piroli G., Grillo A., Reznikov L., Reagen L., McEwen B. Memory impairment in obese Zucker rats: an investigation of cognitive function in an animal model of insulin resistance and obesity. Behav Neurosci 2005, 119:1389-1395.
83. Wu A., Molteni R., Ying Z. A saturated-fat diet aggravates the outcome of traumatic brain injury on hippocampal plasticity and cognitive function by reducing brain-derived neurotrophic factor. Neuroscience 2003, 119:365-375.
84. Xu W., Caracciolo B., Wang H.-X., Winblad B., Bäckman L., Qiu C., Fratiglioni L. Accelerated progression from mild cognitive impairment to dementia in people with diabetes. Diabetes 2010, 59:2928-2935.
85. Yashiro K., Philpot B.D. Regulation of NMDA receptor subunit expression and its implications for LTD, LTP and metaplasticity. Neuropharmacology 2008, 55:1081-1094.
86. Zuo Z.F., Wang W., Niu L., Kou Z.Z., Zhu C., Wang W., Zhao X.H., Luo D.S., Zhang T., Zhang F.X., Liu X.Z., Wu S.X., Li Y.Q. RU486 (mifepristone) ameliorates cognitive dysfunction and reverses the down-regulation of astrocytic N-myc downstream-regulated gene 2 in streptozotocin-induced type-1 diabetic rats. Neuroscience 2011, 190:156-165.